CompletedPhase 1NCT00622674
Bortezomib and Cetuximab in Treating Patients With Advanced Solid Tumors
Studying Sarcoma of cervix uteri
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Masonic Cancer Center, University of Minnesota
- Principal Investigator
- Arkadiusz Dudek, MDMasonic Cancer Center, University of Minnesota
- Intervention
- cetuximab(biological)
- Enrollment
- 37 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2005 – 2010
Study locations (1)
- Masonic Cancer Center at University of Minnesota, Minneapolis, Minnesota, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00622674 on ClinicalTrials.govOther trials for Sarcoma of cervix uteri
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07071727Short Course of Radiotherapy Prior to Surgery of Soft Tissue SarcomasThe Netherlands Cancer Institute
- RECRUITINGPHASE2NCT07192068Clinical Trial Evaluating the Activity of Zanidatamab for the Treatment of Patients With Solid Tumors With an Alteration of the HER2 Gene.UNICANCER
- RECRUITINGPHASE1NCT06771219SLV-154 Treatment of Metastatic Solid TumorsSolve Therapeutics
- RECRUITINGNCT06904365Ovarian-Sparing Adaptive Radiotherapy in Young Adult WomenWashington University School of Medicine
- RECRUITINGPHASE2NCT06580002Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot TrialUniversity of California, Irvine
- RECRUITINGNANCT06103669Locally AblatiVe TherApy in OLigO-pRogressive SOlid TUmorS (VALOROUS)University of California, Davis
- RECRUITINGNCT05366881cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual DiseaseAdela, Inc
- RECRUITINGPHASE1, PHASE2NCT05187338Triplex Checkpoint Inhibitors Therapy for Advanced Solid TumorsSecond Affiliated Hospital of Guangzhou Medical University